This study published in the Journal of Bone and Mineral Research highlights a critical need for new analgesics to promote bone health post-fracture.  The problem with the use of common pain relievers such as NSAIDs is that the anti-inflammatory response could reduce or harm therapeutic outcomes in bone healing.  These researchers from Penn State University conducted a study in mice using Cannabigerol (CBG) and Cannabidiol (CBD), and found that these non-psychoactive cannabinoids actually promote bone health during recovery while providing pain relief.  

Cannabidiol and Cannabigerol, Nonpsychotropic Cannabinoids, as Analgesics that Effectively Manage Bone Fracture Pain and Promote Healing in Mice